xFOREST Therapeutics

xFOREST Therapeutics develops small-molecule therapeutics that target RNA structures of pathogenic genes, leveraging its proprietary FOREST technology suite to identify and optimize RNA-binding compounds. It offers a research platform and drug-discovery services to domestic pharmaceutical companies and is advancing compound optimization platforms to generate clinical drug candidates. The company aims to collaborate with international pharmaceutical partners to expand the global RNA-targeted drug discovery market and accelerate development of RNA-targeted medicines.